Abstract
An increasing proportion of the pharmaceutical armamentarium will in future be composed of peptides and proteins, whether natural or synthetic in origin or, more likely, produced by recombinant DNA technology. Most peptides and proteins are not absorbed to any significant extent by the oral route and most available formulations of protein pharmaceuticals are therefore parenteral products for injection or inhalation (Table 11.1). The object of this chapter is to provide some background for the appreciation of the pharmaceutics of proteins and peptides as therapeutic entities. From an understanding of the nature of amino acids and their physical properties comes an appreciation of the physical nature and properties of polymerised amino acids – peptides, polypeptides and proteins, defined below. The solution properties of proteins in simple and complex media should be understood, together with the factors affecting the stability of proteins in solution. Problems in the formulation of proteins to be overcome will then become clearer.
Preview
Unable to display preview. Download preview PDF.
References
Further reading
R. Oliyar and V. J. Stella. 'Prodrugs of peptides and proteins for improved formulation and delivery.' Ann. Rev. Pharmacol. Toxicol. 32, 521 (1993)
M. C. Manning, K. Patel and R. T. Borchardt. 'Stability of protein pharmaceuticals.' Pharm. Res. 6, 903 ( 1989)
J. L. Cleland, M. F. Powell and S. J. Shire. 'The development of stable protein formulations: a close look at protein aggregation, deoxidation and oxidation.' Crit. Rev. Therap. Drug Carrier Systems 10, 307 (1993)
References
T. E. Creighton, Proteins. 2nd edn, W. H. Freeman, New York, 1993
F. Flam. Science 263, 1562 (1994)
D. Dressler and H. Potter. Discovering Enzymes. Scientific American Library, New York, 1991
J. L. Cleland, M. F. Powell and S. J. Shire. Crit. Rev. Ther. Drug Carrier Systems 10, 307 (1993)
M. C. Manning, K. Patel and R. T. Borchardt. Pharm. Res. 6, 903 (1989)
Y-C. J. Wang and M.A. Hanson. J. Parenter. Sci. Technol. 42, S2 (1988)
T. Chen. Drug Dev. Indust. Pharm. 18, 311 (1992)
J. Brange, D.R. Owens, S. Kang and A. Volund. Diabetes Care 13, 923 (1990)
J. Brange, K. Drejer, J. F. Hansen, S. Havelund, M. C. Kaarsholm, S. G. Melberg and A. R. Sorensen. In Advances in Protein Design, International Workshop 1988 (H. Blocker, J. Collins, R. D. Schmid and D. Schomburg, eds), Chemie Weinheim, Basel, Switzerland, 1989, p. 139
D. N. Brems, P. L. Brown, C. Bryant et al. In Protein Folding: In Vivo and In Vitro (J. Cleland, ed.), ACS Symposium Series, Vol. 526, American Chemical Society, Washington, DC, 1993, p. 254
Z. Shao, Y. Li, R. Krishnamoorthy, T. Chermak and A. K. Mitra. Pharm. Res. 10, 243 (1993)
A. B. Robinson and C. J. Rudd. In Current Topics in Cellular Regulation, Vol. 8 (B. L. Horecker and E. R. Stadtman, eds), Academic Press, New York, 1974, p.247
J. W. Scotchler and A. B. Robinson. Anal. Biochem. 59, 319 (1947)
T. Geiger and S. Clarke. J. Bioi. Chern. 262, 785 (1987)
J. B. Gilbert, C. E. Price and J.P. Greenstein. J. Bioi. Chern. 180, 209 (1949)
S. Capasso, L. Mazzarella and A. Zagari. Peptide Res. 4 (1991)
J. H. McKerrow and A. B. Robinson. Anal. Biochem. 42, 565 (1971)
K. Patel and R. T. Borchardt. Pharm. Res. 7, 703 (1990)
T. Flatmark. Acta Chern. Scand. 20, 1487 (1966)
R. Tyler-Cross and V. Schirch. J. Bioi. Chern. 266, 2549 (1991)
T.V. Brennan and S. Clarke. Protein Sci. 2, 331 (1993)
B. Halliwell and M. C. Gutteridge. In Methods in Enzymology, Vol. 186. Free Radicals and Metal Ions in Human Disease, Academic Press, New York, 1990
C. M. Hariss and R. J. Hill. J. Bioi. Chern. 244, 2195 (1969)
V. Holeysovosky and M. Lazdunski. Biochim. Biophys. Acta 154, 457 (1968)
T. P. Link and G. R. Start. J. Bioi. Chem. 243, 1082 (1968)
W. J. Ray, Jr. and D. E. Koshland, Jr. Brookhaven Symp. Bioi. 13, 135 (1960)
K. Kido and B. Kassel. Biochemistry 14, 631 (1975)
J. Jauregui-Adell and P. Jolles. Bull. Soc. Chim. Bioi. 46, 141 (1964)
J. D. Spikes and R. Straight. Ann. Rev. Phys. Chem. 18, 409 (1967)
G. E. Means and R. E. Feeney. Chemical Modification of Proteins, Holden-Day Inc., San Francisco, 1971, p. 35
B. M. Wallace and J. S. Lasker. Science 260, 912 (1993)
D. A. Paterson, R. A. Conradi, A. R. Hilgers et al. Quantitative Structure-Action Relationships, 13, 4 (1994)
J. L. Cleland and R. Langer. In Formulation and Delivery of Proteins and Peptides (J. L. Cleland and R. Langer, eds), American Chemical Society, Washington, 1994, p.1
J. R. Costantino, R. Langer and A. M. Klibanov. Biotechnology 13, 493 (1995)
M. J. Hageman, P. L. Possert and J. M. Bauer. J. Agric. Food Chem. 40, 342 (1992)
G. Zografi. Drug. Dev. Ind. Pharm. 14, 1905 (1988)
R. Arvinte, A. Cudd and A. F. Drake. J. Bioi. Chem. 268, 6415 (1993)
Author information
Authors and Affiliations
Copyright information
© 1998 A. T. Florence and D. Attwood
About this chapter
Cite this chapter
Florence, A.T., Attwood, D. (1998). Peptides and Proteins. In: Physicochemical Principles of Pharmacy. Palgrave, London. https://doi.org/10.1007/978-1-349-14416-7_12
Download citation
DOI: https://doi.org/10.1007/978-1-349-14416-7_12
Publisher Name: Palgrave, London
Print ISBN: 978-0-333-69081-9
Online ISBN: 978-1-349-14416-7
eBook Packages: EngineeringEngineering (R0)